Rev Esp Quimioter 2022;35(Suppl.2):45-47

Cefiderocol. Summary and conclusions

JOSÉ MENSA, JOSÉ BARBERÁN

Published: 4 October 2022

http://www.doi.org/10.37201/req/s02.07.2022

Rev Esp Quimioter 2022; 35(Suppl. 2):45-47 [Full-text PDF]